Renaissance Technologies raised its position and increased holdings in Bausch Health stock, while also dropping its target price.
1 report, 1 independent
Updated Aug 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Renaissance Technologies raised its position and increased holdings in Bausch Health stock, while also dropping its target price.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bausch Health
multinational specialty drugs company based in Laval, Quebec, Canada
Nothing else this week.
-
Renaissance Technologies
American hedge fund firm
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada raised its target price for BNY Corp and acquired a new stake in the company's shares on August 31, 2026.
- Central bank increased its stake in Corpay shares while Royal Bank of Canada raised its target price for the company.
- Multiple financial firms made various stake adjustments in SLB shares, while TD Cowen lifted its price target and gave a 'buy' rating.
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- Analyst upgraded rating and set price target for Pound Medical, and Royal Bank of Canada increased its share holdings.